Van Ess PJ[au] - Search Results

Year	Number of Results
1993	1
1994	1
2001	1
2002	3
2017	1
2019	2
2020	1
2021	1
2022	0

1

Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray.

Bouw MR, Chung SS, Gidal B, King A, Tomasovic J, Wheless JW, Van Ess PJ. Bouw MR, et al. Among authors: van ess pj. Epilepsy Res. 2021 Mar;171:106567. doi: 10.1016/j.eplepsyres.2021.106567. Epub 2021 Feb 3. Epilepsy Res. 2021. PMID: 33607532 Free article. Review.

2

Safety and efficacy of midazolam nasal spray for the treatment of intermittent bouts of increased seizure activity in the epilepsy monitoring unit: A double-blind, randomized, placebo-controlled trial.

Spencer DC, Sinha SR, Choi EJ, Cleveland JM, King A, Meng TC, Pullman WE, Sequeira DJ, Van Ess PJ, Wheless JW. Spencer DC, et al. Among authors: van ess pj. Epilepsia. 2020 Nov;61(11):2415-2425. doi: 10.1111/epi.16704. Epub 2020 Nov 2. Epilepsia. 2020. PMID: 33140403 Clinical Trial.

3

Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo-controlled trial.

Detyniecki K, Van Ess PJ, Sequeira DJ, Wheless JW, Meng TC, Pullman WE. Detyniecki K, et al. Among authors: van ess pj. Epilepsia. 2019 Sep;60(9):1797-1808. doi: 10.1111/epi.15159. Epub 2019 May 29. Epilepsia. 2019. PMID: 31140596 Free PMC article. Clinical Trial.

4

Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters: An open-label extension trial.

Wheless JW, Meng TC, Van Ess PJ, Detyniecki K, Sequeira DJ, Pullman WE. Wheless JW, et al. Among authors: van ess pj. Epilepsia. 2019 Sep;60(9):1809-1819. doi: 10.1111/epi.16300. Epub 2019 Jul 29. Epilepsia. 2019. PMID: 31353457 Clinical Trial.

5

Pharmacokinetics, pharmacodynamics, and tolerability of USL261, midazolam nasal spray: Randomized study in healthy geriatric and non-geriatric adults.

Berg AK, Myrvik MJ, Van Ess PJ. Berg AK, et al. Among authors: van ess pj. Epilepsy Behav. 2017 Jun;71(Pt A):51-59. doi: 10.1016/j.yebeh.2017.02.023. Epub 2017 May 23. Epilepsy Behav. 2017. PMID: 28544992 Free article. Clinical Trial.

6

Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response.

Warren GW, van Ess PJ, Watson AM, Mattson MP, Blouin RA. Warren GW, et al. Among authors: van ess pj. J Interferon Cytokine Res. 2001 Oct;21(10):821-6. doi: 10.1089/107999001753238060. J Interferon Cytokine Res. 2001. PMID: 11710994

7

Elevated hepatic and depressed renal cytochrome P450 activity in the Tg2576 transgenic mouse model of Alzheimer's disease.

Van Ess PJ, Pedersen WA, Culmsee C, Mattson MP, Blouin RA. Van Ess PJ, et al. J Neurochem. 2002 Feb;80(4):571-8. doi: 10.1046/j.0022-3042.2001.00724.x. J Neurochem. 2002. PMID: 11841564 Free article.

8

Enhanced induction of cytochrome P450 enzymes and CAR binding in TNF (p55(-/-)/p75(-/-)) double receptor knockout mice following phenobarbital treatment.

Van Ess PJ, Mattson MP, Blouin RA. Van Ess PJ, et al. J Pharmacol Exp Ther. 2002 Mar;300(3):824-30. doi: 10.1124/jpet.300.3.824. J Pharmacol Exp Ther. 2002. PMID: 11861787

9

Blunted induction of hepatic CYP4A in TNF (p55-/-/p75-/-) double receptor knockout mice following clofibrate treatment.

Van Ess PJ, Poloyac S, Mattson MP, Blouin RA. Van Ess PJ, et al. Pharm Res. 2002 May;19(5):708-12. doi: 10.1023/a:1015326717522. Pharm Res. 2002. PMID: 12069177 No abstract available.

10

Localization of epidermal growth factor receptors in first- and third-trimester human placentas.

Duello TM, Bertics PJ, Fulgham DL, Van Ess PJ. Duello TM, et al. Among authors: van ess pj. J Histochem Cytochem. 1994 Jul;42(7):907-15. doi: 10.1177/42.7.8014474. J Histochem Cytochem. 1994. PMID: 8014474

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results